Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States

Medicine & Life Sciences

• African Continental Ancestry Group 4%
• CD4 Lymphocyte Count 10%
• Cohort Studies 3%
• Contraindications 4%
• Drug Users 5%
• Education 3%
• Guidelines 3%
• Heterosexuality 5%
• Highly Active Antiretroviral Therapy 100%
• HIV 13%
• HIV Infections 78%
• Insurance 5%
• Interviews 16%
• Logistic Models 6%
• Medicaid 5%
• Minority Groups 6%
• Odds Ratio 6%
• Population 1%
• Population Characteristics 5%
• Prospective Studies 3%
• Regression Analysis 6%
• Sampling Studies 6%
• United States Dept. of Health and Human Services 7%